Login / Signup

Si-Ni-San Reduces Hepatic Lipid Deposition in Rats with Metabolic Associated Fatty Liver Disease by AMPK/SIRT1 Pathway.

Ning ZhangTong LiuJianan WangYingying XiaoYing ZhangJun DaiZhi Hong MaDonglai Ma
Published in: Drug design, development and therapy (2023)
SNS could reduce hepatic lipid deposition by inhibiting lipid synthesis and promoting fatty acid oxidation, which might be related with activating the AMPK/SIRT1 signaling pathway. This study could provide a theoretical basis for the clinical use of SNS to treat MAFLD.
Keyphrases
  • fatty acid
  • signaling pathway
  • skeletal muscle
  • pi k akt
  • ischemia reperfusion injury
  • epithelial mesenchymal transition
  • protein kinase
  • induced apoptosis
  • nitric oxide
  • room temperature